Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

DSM announces agreements with Biomedical Structures, Cortland and Secant Medical

DSM, which created and manufactures Dyneema Purity, the world's strongest Medical grade fiber, today announced agreements with Biomedical Structures, Cortland Company and Secant Medical. These companies' experience in processing Dyneema Purity fiber in biomedical textile structures offers medical device companies the ability to use various constructions of Dyneema Purity, including the recently launched Dyneema Purity BLUE, in commercial medical devices.

9 Jun 2010

Vertellus announces new 3-cyanopyridine production unit at Nantong facility

Vertellus Specialties Inc. announced today that it will break ground on a new 3-cyanopyridine production unit at Vertellus' production facility in Nantong, Jiangsu, China. This unit is a continuation of a larger effort to expand production capacity in Nantong. It will increase Vertellus' Vitamin B3 manufacturing capacity in the region by 10,000 metric tons. The capacity increase will enable Vertellus to maintain its position as the world's second largest provider of Vitamin B3 and the largest producer of cyanopyridines in the world.

8 Jun 2010

MiMedx' HydroFix Vaso Shield receives FDA clearance for additional thicknesses and sizes

MiMedx Group, Inc., an integrated developer, manufacturer and marketer of patent protected biomaterial-based products, announced today that it has received notification by the FDA that the Company's proprietary device, HydroFix™ Vaso Shield, has received 510(k) clearance for additional thicknesses and sizes.

7 Jun 2010

Simcere Pharmaceutical to increase stake in Jilin Boda

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today announced that it has entered into an agreement to acquire an 80% stake in Xiangao Investment Company Ltd, an investment company registered in China, as its sole business, holds a 49% stake in Jilin Boda Pharmaceutical Co. Ltd..

7 Jun 2010

Raydiance, Rofin partner to offer femtosecond laser technology for manufacture of medical devices

Raydiance, Inc., the innovation leader in ultrafast laser technology, announced today that it is teaming up with Rofin, world-leading manufacturer of laser sources and laser-based solutions for industrial materials processing, to introduce femtosecond laser technology to industrial production.

7 Jun 2010

Grifols to acquire Talecris Biotherapeutics

Grifols a global healthcare company and leading producer of plasma protein therapies, and Talecris a U.S.-based biotherapeutics products company, today announced that they have signed a definitive agreement through which Grifols will acquire Talecris for a combination of cash and newly-issued Grifols non-voting shares having an aggregate value today of approximately $3.4 billion (euro 2.8 billion), creating a global leader of life-saving and life enhancing plasma protein therapeutics.

7 Jun 2010

Walter Reed Army Medical Center to treat pain patients with CTT's Calmare Pain Therapy Treatment

Competitive Technologies, Inc. announced today that the Walter Reed Army Medical Center in Washington, D.C., has joined the growing list of organizations that will treat pain patients with CTT's Calmare Pain Therapy Treatment, as authorized by the Surgeon General of the U.S. Army and Commanding General of the U.S. Army Medical Command.

5 Jun 2010

Cardinal Health and UW collaborate to advance use of molecular imaging in clinical investigations and trials

Cardinal Health and the University of Washington (UW) today announced an innovative public-private collaboration designed to advance the use of molecular imaging in clinical investigations and trials.

4 Jun 2010

Millipore shareholders approve acquisition of all outstanding shares of common stock by Merck KGaA

Millipore Corporation, a leading provider of technologies, tools and services for the global life science industry, today announced that its shareholders voted at a Special Meeting of Shareholders to approve the previously-announced acquisition of all outstanding shares of common stock of Millipore by Merck KGaA of Germany, the global pharmaceutical and chemical company.

4 Jun 2010

Malvern publishes online chemical imaging bibliography

By combining conventional spectroscopy with sophisticated mapping and imaging technology in its SyNIRgi chemical imaging system and ISys chemical imaging software, Malvern Panalytical has greatly extended the application of vibrational spectroscopy.

From Malvern Panalytical 3 Jun 2010

Ocutec receives further equity investment of £500K from existing investors

Ocutec Ltd, the Lanarkshire-based medical devices company, today announced that it had received a further equity investment of £500K from existing investors Discovery Investment Fund Limited, Chimaerabio, Scottish Enterprise Co-investment Fund and company founders.

3 Jun 2010

New 'dipstick' test determines blood types instantly

Scientists are reporting development of the first "dipstick" test for instantly determining a person's blood type at a cost of just a few pennies. Their study on the test, which involves placing a drop of blood on a specially treated paper strip, appears in ACS' semi-monthly journal Analytical Chemistry, where the authors say it could be a boon to health care in developing countries.

3 Jun 2010

Insulin pills to manage diabetes are finally moving ahead in clinical trials

After years of research and anticipation, insulin pills that could make it easier for millions of patients worldwide to manage diabetes are finally moving ahead in clinical trials and a step-closer to the medicine cabinet. That's among the topics highlighted in a two-part cover story on drug manufacturing in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine.

3 Jun 2010

Amedica secures US patent for novel hip implant

Amedica Corporation, a spinal and orthopaedic implant and instrument manufacturer focused on unique silicon nitride (SiN) ceramic technologies, announced today that it has been granted United States Patent No. 7,695,521 covering its novel hip implant featuring a monoblock ceramic acetabular cup for use in articulating joints for total joint replacement.

3 Jun 2010

IntriCon completes divestiture of RTI Electronics

IntriCon Corporation, a designer, developer, manufacturer and distributor of body-worn medical and electronics devices, today announced that it has completed the previously announced divestiture of its non-core electronics business, Anaheim, Calif.-based RTI Electronics, Inc. IntriCon has sold the business to an affiliate of Shackleton Equity Partners, a Los Angeles-based private equity group.

2 Jun 2010

Competitive Technologies to raise over $5M to accelerate sales of Calmare Pain Therapy Treatment

Competitive Technologies, Inc. today announced that it has signed an agreement to raise over $5 million by selling 2 million shares of equity to Crisnic Fund, S.A. based on a 15% discount from the volume weighted average price on the date the SEC declares the registration effective, as detailed in the 8-K being filed today.

2 Jun 2010

Emerson Ecologics announces awardees of Partner status in Emerson Quality Program

Emerson Ecologics, LLC announces the debut of the first group of manufacturers to be awarded Partner status in the Emerson Quality Program(SM) (EQP). This one-of-a-kind quality assurance program for the nutritional supplements industry provides practitioners with manufacturer-specific quality and safety information to assist in confidently recommending the best products to patients.

2 Jun 2010

FDA approves Prolia for postmenopausal women with osteoporosis

The U.S. Food and Drug Administration approved Prolia, an injectable treatment for postmenopausal women with osteoporosis who are at high risk for fractures.

2 Jun 2010

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

Targeted Genetics Corporation today announced its financial results for the fourth quarter and full year ended December 31, 2009.

1 Jun 2010

P2i completes £5.5m fund raising to support its international growth

P2i Limited, the world leader in liquid repellent nano-coating technology, has completed a £5.5m fund raising, to provide further working capital to support its rapid international growth. The funding has come from existing shareholders, Naxos Capital Partners, Swarraton Partners, Porton Capital, Unilever Ventures and Rainbow Seedfund.

1 Jun 2010

Manufacturing News and Research

Further Reading

DSM announces agreements with Biomedical Structures, Cortland and Secant Medical

Vertellus announces new 3-cyanopyridine production unit at Nantong facility

MiMedx' HydroFix Vaso Shield receives FDA clearance for additional thicknesses and sizes

Simcere Pharmaceutical to increase stake in Jilin Boda

Raydiance, Rofin partner to offer femtosecond laser technology for manufacture of medical devices

Grifols to acquire Talecris Biotherapeutics

Walter Reed Army Medical Center to treat pain patients with CTT's Calmare Pain Therapy Treatment

Cardinal Health and UW collaborate to advance use of molecular imaging in clinical investigations and trials

Millipore shareholders approve acquisition of all outstanding shares of common stock by Merck KGaA

Malvern publishes online chemical imaging bibliography

Ocutec receives further equity investment of £500K from existing investors

New 'dipstick' test determines blood types instantly

Insulin pills to manage diabetes are finally moving ahead in clinical trials

Amedica secures US patent for novel hip implant

IntriCon completes divestiture of RTI Electronics

Competitive Technologies to raise over $5M to accelerate sales of Calmare Pain Therapy Treatment

Emerson Ecologics announces awardees of Partner status in Emerson Quality Program

FDA approves Prolia for postmenopausal women with osteoporosis

Targeted Genetics reports net income of $1.8M for fourth-quarter 2009 compared to net loss of $10.8M in 2008

P2i completes £5.5m fund raising to support its international growth

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News